Filing Details

Accession Number:
0001209191-19-039770
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-01 17:01:19
Reporting Period:
2019-06-27
Accepted Time:
2019-07-01 17:01:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604464 Atara Biotherapeutics Inc. ATRA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202785 Eric Dobmeier C/O Atara Biotherapeutics, Inc.
611 Gateway Boulevard, Suite 900
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-27 2,000 $19.50 16,000 No 4 P Direct
Common Stock Acquisiton 2019-06-27 4,000 $0.00 20,000 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (Right to Buy) Acquisiton 2019-06-27 13,000 $0.00 13,000 $20.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,000 2029-06-26 No 4 A Direct
Footnotes
  1. These restricted stock units shall vest on the earlier of June 27, 2020 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.
  2. The option shall vest on the earlier of June 27, 2020 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.